221 related articles for article (PubMed ID: 20491725)
1. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
Hahn JA; Evans JL; Davidson PJ; Lum PJ; Page K
Addiction; 2010 Jul; 105(7):1254-64. PubMed ID: 20491725
[TBL] [Abstract][Full Text] [Related]
2. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.
Morris MD; Evans J; Montgomery M; Yu M; Briceno A; Page K; Hahn JA
PLoS One; 2014; 9(10):e109282. PubMed ID: 25286346
[TBL] [Abstract][Full Text] [Related]
3. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.
Evans JL; Morris MD; Yu M; Page K; Hahn JA
Drug Alcohol Depend; 2014 Sep; 142():239-44. PubMed ID: 25034898
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).
Evans JL; Hahn JA; Page-Shafer K; Lum PJ; Stein ES; Davidson PJ; Moss AR
J Urban Health; 2003 Mar; 80(1):137-46. PubMed ID: 12612103
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.
Morris MD; Neilands TB; Andrew E; Maher L; Page KA; Hahn JA
Int J Drug Policy; 2017 Oct; 48():54-62. PubMed ID: 28804051
[TBL] [Abstract][Full Text] [Related]
6. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
Kim NJ; Jin H; McFarland W; Raymond HF
Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.
Hahn JA; Page-Shafer K; Lum PJ; Ochoa K; Moss AR
Hepatology; 2001 Jul; 34(1):180-7. PubMed ID: 11431749
[TBL] [Abstract][Full Text] [Related]
8. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
Harris M; Rhodes T
Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
[TBL] [Abstract][Full Text] [Related]
9. Traveling young injection drug users at high risk for acquisition and transmission of viral infections.
Hahn JA; Page-Shafer K; Ford J; Paciorek A; Lum PJ
Drug Alcohol Depend; 2008 Jan; 93(1-2):43-50. PubMed ID: 17980513
[TBL] [Abstract][Full Text] [Related]
10. Risk behaviors for HIV in sexual partnerships of San Francisco injection drug users.
Chen YH; McFarland W; Raymond HF
AIDS Care; 2014; 26(5):554-8. PubMed ID: 24093881
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in injection risk behaviors at the first injection episode.
Frajzyngier V; Neaigus A; Gyarmathy VA; Miller M; Friedman SR
Drug Alcohol Depend; 2007 Jul; 89(2-3):145-52. PubMed ID: 17276623
[TBL] [Abstract][Full Text] [Related]
12. Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting.
Bryant J; Brener L; Hull P; Treloar C
Drug Alcohol Depend; 2010 Mar; 107(2-3):182-7. PubMed ID: 19942380
[TBL] [Abstract][Full Text] [Related]
13. Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.
Burt RD; Thiede H; Hagan H
Drug Alcohol Depend; 2009 Dec; 105(3):215-20. PubMed ID: 19720473
[TBL] [Abstract][Full Text] [Related]
14. Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics.
Montgomery ME; Fatch RS; Evans JL; Yu M; Davidson PJ; Page K; Hahn JA
J Urban Health; 2013 Jun; 90(3):500-15. PubMed ID: 22744293
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
Hahn JA; Page-Shafer K; Lum PJ; Bourgois P; Stein E; Evans JL; Busch MP; Tobler LH; Phelps B; Moss AR
J Infect Dis; 2002 Dec; 186(11):1558-64. PubMed ID: 12447730
[TBL] [Abstract][Full Text] [Related]
16. "To share or not to share?" Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants.
Smith BD; Jewett A; Burt RD; Zibbell JE; Yartel AK; DiNenno E
J Infect Dis; 2013 Dec; 208(12):1934-42. PubMed ID: 24136794
[TBL] [Abstract][Full Text] [Related]
17. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
[TBL] [Abstract][Full Text] [Related]
18. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors.
Le Marchand C; Evans J; Page K; Davidson PJ; Hahn JA
Drug Alcohol Depend; 2013 Jan; 127(1-3):143-9. PubMed ID: 22819868
[TBL] [Abstract][Full Text] [Related]
19. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
Falster K; Kaldor JM; Maher L;
J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
